Medidata announced the completion of MOVE-2014, a behavioral study it sponsored to test whether mobile health (mHealth) devices and tools could be used to drive better health outcomes in overweight adults with Type-2 Diabetes.
PRC Clinical, a CRO specializing in clinical trial management, is joining the Alliance for Regenerative Medicine (ARM).
inVentiv Health, a global provider of clinical development and comprehensive commercialization services, announced expansion of compliance products and services to assist biopharmaceutical companies conducting non-interventional studies globally.
Quotient Clinical has announced results from an Enabled-First-in-Human (Enabled-FIH) program conducted for the Janssen WAVE Early Development unit.
Throughout this trial, YPrime will be supporting world class selected sites to conduct the study with data driven metrics pulled from these tools. YPrime is dedicated to applying its leading edge eClinical technology to help forward unmet medical needs in the Biotech and Pharmaceutical industry.